New Weight-Loss drug candidate enters human testing
Disease control
Recruiting now
This study is testing an experimental drug called ALV-100 in 180 adults who are overweight or obese, some of whom also have type 2 diabetes. The main goal is to check the drug's safety and how the body processes it. Participants will receive either the drug or a placebo, and rese…
Phase: PHASE1 • Sponsor: Alveus Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 11:53 UTC